Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness
- PMID: 11448151
- DOI: 10.1006/pupt.2001.0296
Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness
Abstract
Glycosaminoglycans (GAGs) are large, polyanionic molecules expressed throughout the body. The GAG heparin, co-released with histamine, is synthesised by and stored exclusively in mast cells, whereas the closely related molecule heparan sulphate is expressed, as part of a proteoglycan, on cell surfaces and throughout tissue matrices. These molecules are increasingly thought to play a role in regulation of the inflammatory response and heparin, for many years, has been considered to hold potential in the treatment of diseases such as asthma. Heparin and related molecules have been found to exert antiinflammatory effects in a wide range of in vitro assays, animal models and, indeed, human patients. Moreover, the results of studies carried out to date indicate that the antiinflammatory activities of heparin are dissociable from its well-established anticoagulant nature, suggesting that the separation of these characteristics could yield novel antiinflammatory drugs which may be useful in the future treatment of diseases such as asthma
Copyright Academic Press.
Similar articles
-
Glycosaminoglycans and the regulation of allergic inflammation.Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):221-5. doi: 10.2174/1568010043343589. Curr Drug Targets Inflamm Allergy. 2004. PMID: 15446270 Review.
-
Mechanisms for the anticoagulant effect of heparin and related polysaccharides.Nouv Rev Fr Hematol (1978). 1988;30(3):155-60. Nouv Rev Fr Hematol (1978). 1988. PMID: 2971155 Review.
-
Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.Basic Clin Pharmacol Toxicol. 2012 Nov;111(5):296-302. doi: 10.1111/j.1742-7843.2012.00906.x. Epub 2012 Jul 6. Basic Clin Pharmacol Toxicol. 2012. PMID: 22672269
-
Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells.Braz J Med Biol Res. 2001 Jun;34(6):699-709. doi: 10.1590/s0100-879x2001000600002. Braz J Med Biol Res. 2001. PMID: 11378657 Review.
-
Anticoagulant properties in vitro of heparan sulphates.Thromb Res. 1984 Sep 1;35(5):567-76. doi: 10.1016/0049-3848(84)90288-3. Thromb Res. 1984. PMID: 6237461
Cited by
-
Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.Cells. 2020 Aug 5;9(8):1838. doi: 10.3390/cells9081838. Cells. 2020. PMID: 32764324 Free PMC article. Review.
-
Extracellular Matrix Component Remodeling in Respiratory Diseases: What Has Been Found in Clinical and Experimental Studies?Cells. 2019 Apr 11;8(4):342. doi: 10.3390/cells8040342. Cells. 2019. PMID: 30979017 Free PMC article. Review.
-
Mast cells protect mice from Mycoplasma pneumonia.Am J Respir Crit Care Med. 2006 Jan 15;173(2):219-25. doi: 10.1164/rccm.200507-1034OC. Epub 2005 Oct 6. Am J Respir Crit Care Med. 2006. PMID: 16210667 Free PMC article.
-
Reduction of Asthmatic Parameters by Sea Hare Hydrolysates in a Mouse Model of Allergic Asthma.Nutrients. 2017 Jul 5;9(7):699. doi: 10.3390/nu9070699. Nutrients. 2017. PMID: 28678189 Free PMC article.
-
Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.J Aerosol Med Pulm Drug Deliv. 2014 Feb;27(1):12-20. doi: 10.1089/jamp.2013.1073. Epub 2013 Nov 28. J Aerosol Med Pulm Drug Deliv. 2014. PMID: 24286441 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical